CDH6 and cancer: Moreover, it has been demonstrated in highly metastatic PTCs that CDH6 expression, a class II cadherin aberrantly reactivated in cancer, is restricted to EMT cells that also exhibit a higher incidence of TERT amplification, a finding that raises the hypothesis of a putative functional connection of both events in EMT activation and metastatic spreading [38, 39].